← Back to all trials
Active Not Recruiting
NCT05632055
miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction
Conditions: Gestational Diabetes
Sex: Female
Healthy volunteers: 1
Enrollment: 160
Sponsor: ChaingMai University
Location: Thailand
Summary
The goal of this observational study is to compare miRNA and FGF21 in pregnancy with and without GDM (Gestational Diabetes) The main question it aims to answer that miRNA and FGF21 are different between two groups.Participants will be retrieved blood sample during first trimester and undergone 100 gm OGTT (oral glucose challenge test) during 24-28 weeks of gestation.
Eligibility Criteria
Inclusion Criteria:singleton pregnant women who attend at our clinic in first trimesterExclusion Criteria:known underlying disease such as chronic hypertension, pregestational diabetes, SLEnormal structural fetal anatomical screeningincomplete obstetric data
Source: ClinicalTrials.gov (NCT05632055). StuddyBuddy aggregates publicly available trial information.
